搡老女人多毛老妇女中国,日韩亚洲欧美中文高清在线,人妻少妇一区二区三区,色妞色综合久久夜夜,日本熟妇xxxx

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Arabidopsis thaliana DNA mismatch repair protein MSH6 (MSH6), partial CSB-YP519077DOA
CSB-EP519077DOA
CSB-BP519077DOA
CSB-MP519077DOA
CSB-EP519077DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eustoma exaltatum subsp. russellianum Flavonoid 3',5'-hydroxylase (CYP75A7), partial CSB-YP519078EPS
CSB-EP519078EPS
CSB-BP519078EPS
CSB-MP519078EPS
CSB-EP519078EPS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Eucalyptus gunnii Caffeoyl-CoA O-methyltransferase CSB-YP519079EOZ
CSB-EP519079EOZ
CSB-BP519079EOZ
CSB-MP519079EOZ
CSB-EP519079EOZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Alnus glutinosa Acetylornithine aminotransferase, mitochondrial (AG118), partial CSB-YP519080AZS
CSB-EP519080AZS
CSB-BP519080AZS
CSB-MP519080AZS
CSB-EP519080AZS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Amaranthus hypochondriacus Betaine aldehyde dehydrogenase, chloroplastic (BADH4) CSB-YP519081BYA
CSB-EP519081BYA
CSB-BP519081BYA
CSB-MP519081BYA
CSB-EP519081BYA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Arabidopsis thaliana Probable glutathione peroxidase 2 (GPX2) CSB-YP519082DOA
CSB-EP519082DOA
CSB-BP519082DOA
CSB-MP519082DOA
CSB-EP519082DOA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Phaseolus vulgaris Leghemoglobin CSB-YP519083EUN
CSB-EP519083EUN
CSB-BP519083EUN
CSB-MP519083EUN
CSB-EP519083EUN-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solanum pennellii 2-isopropylmalate synthase B (IPMSB), partial CSB-YP519084SZZ
CSB-EP519084SZZ
CSB-BP519084SZZ
CSB-MP519084SZZ
CSB-EP519084SZZ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Solidago canadensis var. scabra Superoxide dismutase [Cu-Zn], chloroplastic (SODCP) CSB-YP519085FIJ
CSB-EP519085FIJ
CSB-BP519085FIJ
CSB-MP519085FIJ
CSB-EP519085FIJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase (ispD) CSB-YP519086HTA
CSB-EP519086HTA
CSB-BP519086HTA
CSB-MP519086HTA
CSB-EP519086HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Mu-like prophage FluMu G protein 1 (HI_1503) CSB-YP519087HTA
CSB-EP519087HTA
CSB-BP519087HTA
CSB-MP519087HTA
CSB-EP519087HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Haemophilus influenzae Uncharacterized transposase-like protein HI_1721 (HI_1721) CSB-YP519088HTA
CSB-EP519088HTA
CSB-BP519088HTA
CSB-MP519088HTA
CSB-EP519088HTA-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Ehrlichia chaffeensis Quinolinate synthase A (nadA) CSB-YP519089EJS
CSB-EP519089EJS
CSB-BP519089EJS
CSB-MP519089EJS
CSB-EP519089EJS-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Malate synthase G (glcB), partial CSB-YP519090FFT
CSB-EP519090FFT
CSB-BP519090FFT
CSB-MP519090FFT
CSB-EP519090FFT-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Glycyl-glycine endopeptidase ALE-1 CSB-YP519091FLJ
CSB-EP519091FLJ
CSB-BP519091FLJ
CSB-MP519091FLJ
CSB-EP519091FLJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized transporter YwrA (ywrA), partial CSB-YP519092BRJ1
CSB-EP519092BRJ1
CSB-BP519092BRJ1
CSB-MP519092BRJ1
CSB-EP519092BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Uncharacterized protein ywrE (ywrE), partial CSB-YP519093BRJ1
CSB-EP519093BRJ1
CSB-BP519093BRJ1
CSB-MP519093BRJ1
CSB-EP519093BRJ1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Na (+)/H (+) antiporter subunit D, partial CSB-YP519094BRJ
CSB-EP519094BRJ
CSB-BP519094BRJ
CSB-MP519094BRJ
CSB-EP519094BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Probable oligo-1,6-glucosidase 3 (yugT), partial CSB-YP519095BRJ
CSB-EP519095BRJ
CSB-BP519095BRJ
CSB-MP519095BRJ
CSB-EP519095BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Bacillus subtilis Sensor histidine kinase malK (malK), partial CSB-YP519096BRJ
CSB-EP519096BRJ
CSB-BP519096BRJ
CSB-MP519096BRJ
CSB-EP519096BRJ-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見問(wèn)題。您可以單擊以下鏈接查看。http://www.pptc.cn/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>